Department of Thoracic Surgery I, Peking University Cancer Hospital, Chief Physician, Associate Professor, Master's Supervisor. Specialties: Comprehensive therapy dominated by surgical operations for malignant thoracic tumors. In addition to routinely performing minimally‑invasive lung cancer surgery and mediastinal surgery, he is especially skilled in surgical treatment of various complex esophageal cancers, including treatment of high cervical esophageal cancer, salvage esophageal surgery after definitive chemoradiotherapy, surgical intervention for recurrent esophageal cancer following gastric cancer surgery, and combined organ resection for esophageal cancer. His main research focus lies in comprehensive treatment of locally advanced esophageal cancer. He has received training in minimally‑invasive thoracic tumor surgery at the Department of Thoracic Surgery of Duke University Medical Center in the United States and the Esophageal Surgery Division of the National Cancer Center in Japan. Representative Achievements:‑Research Projects 1. Beijing Excellent Talent Training Program (2020‑2022): A multicenter randomized controlled study comparing neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy combined with minimally‑invasive surgery for locally advanced resectable esophageal squamous cell carcinoma 2. Outstanding Program for Research‑oriented Wards of Beijing Municipal Health Bureau (2024‑2027): A randomized controlled study on real‑time intraoperative nerve function monitoring to reduce recurrent laryngeal nerve injury during lymph node dissection for esophageal cancer‑